Rigenerand Competitors and Similar CompaniesClear all

Immunochina's competitors and similar companies include Fusion Pharmaceuticals, Shoreline Biosciences and TScan Therapeutics.

	Immunochina Immunochina is a company that specializes in applying CAR-T technology and gene cell drugs to the treatment of malignant tumors.	Fusion Pharmaceuticals Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer.	Shoreline Biosciences Shoreline Biosciences is a biotechnology company that provides proprietary cell therapy technology platforms.	TScan Therapeutics TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.
Founding Date	Founding Date 2015	Founding Date 2014	Founding Date 2020	Founding Date 2018
Type	Type Private	Type Subsidiary	Type Private	Type Public
Tags	Tags Technology biotech drug development oncology pharma	Tags Technology biotech oncology pharma therapy	Tags Technology biotech oncology pharma therapy	Tags Technology biotech oncology pharma therapy
Locations	Locations CN HQ	Locations Hamilton, CA HQ Boston, US	Locations San Diego, US HQ San Diego, US	Locations Waltham, US HQ
Employees	Employees 205% increase	Employees 101	Employees 4716% decrease	Employees 7316% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $2.1m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) $10.3m (FY, 2025)
Net income	Net income N/A	Net income ($94.9m) (FY, 2023)	Net income N/A	Net income ($129.8m) (FY, 2025)
Funding
Latest funding round	Latest funding round $ 20.6m (over 7 years ago)	Latest funding round N/A	Latest funding round $ 43m (about 5 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 28.1m	Total funding raised $ 170.9m	Total funding raised $ 46m	Total funding raised $ 137.5m